In this issue:
Statins reduce risk of VTE recurrence
Perioperative oral eltrombopag vs. IVIG for ITP
No differences in outcomes between JAK2 V617F VAFs <2% vs. 2–10%
Hypomethylating agents in MDS with chromosome 3 abnormalities
Adults with HLH have inflammatory profile rather than cytotoxicity defect
Predicting EFS after SCT for sickle cell disease
MRD better than mutations for predicting outcome in AML with biallelic CEBPA mutations?
Haematological features, transfusions and outcomes of massive obstetric haemorrhage
Real-world eliglustat use in Gaucher disease type 1
Venetoclax-based salvage for post-SCT relapse of AML
Please login below to download this issue (PDF)